Conclusion and responsible use
A single untuned substrate yields a falsifiable corrective direction for hundreds of rare diseases and, in hundreds of cases, recovers medicine already in use. The proper response to any page is a controlled experiment, never clinical action. No dose appears anywhere; dosing belongs to physicians and regulators, not to a reader of this site.
One untuned geometry, applied uniformly, yields a falsifiable corrective direction for hundreds of rare diseases — and, in hundreds of cases, recovers medicine already in use. That is the whole contribution, and its only proper use is expert evaluation.
What was shown
- A single substrate (the R19 bistable switch) emerges a corrective direction for 839 rare diseases, each graded [F] and shipped with a falsifier.
- In 322 diseases that untuned direction recovers an agent already in clinical use — independent validation of the logic.
- 29 diseases receive a novel, direction-only, falsifiable lead; 488 are kept as honest holds.
- The entire corpus is no-tuning, hash-chained, and bit-for-bit reproducible, and passes a zero-leak magnitude-firewall check.
Responsible use
This volume is a hypothesis generator for experts. The correct response to any page is to design a controlled experiment, not to act on it clinically. It is not medical advice, not a prescription, and not an approved method. No dose appears anywhere, and that omission is load-bearing: dosing is unvalidated and belongs to a licensed physician or a national regulatory authority, never to a reader of this site.